Metabolism - Clinical and Experimental
Volume 47, Issue 8 , Pages 929-933, August 1998

Effect of visceral fat accumulation on uric acid metabolism in male obese subjects: Visceral fat obesity is linked more closely to overproduction of uric acid than subcutaneous fat obesity

Second Department of Internal Medicine, Osaka University Medical School, Osaka, Japan

Received 15 July 1997; accepted 9 February 1998.

Abstract 

We investigated the relationship between uric acid (UA) metabolism and fat distribution in 36 obese men with a mean ± SD age of 38 ± 16 years and mean body-mass index (BMI) of 34 ± 4 kg/m2. Subjects were divided into two groups: subcutaneous fat obesity (SFO) and visceral fat obesity (VFO), according to their abdominal fat distribtion based on the results of computed tomography (CT). SFO was defined as having a ratio of visceral fat area (VFA) to subcutaneous fat area () of less than 0.4, and VFO was defined as having a ratio ≥ 0.4. The levels of serum total cholesterol (T-Chol), triglyceride (TG), and fasting plasma glucose (FPG), and the diastolic blood pressure (dBP) were significantly higher in the VFO group than in the SFO group. Serum UA levels were much higher in both the SFO and VFO groups than in the non-obese control group (492 ± 107 and 474 ± 90 v 309 ± 48 μmol/L, respectively). The 24-hour urinary urate excretion (u-UA24h) and the UA clearance (Cua) to creatinine clearance (Ccr) ratio were significantly higher in the VFO group than in the SFO group (3.75 ± 1.43 v 2.69 ± 1.12 mmol/d, P < .05; and 5.9% ± 2.0% v 3.6% ± 1.7%, P < .001, respectively). The frequency of hyperuricemia was markedly higher in both the SFO and VFO groups compared with the control group (71% and 73% v 0%, respectively). Although the high serum UA level seemed to be related to low u-UA24h in 80% of SFO subjects with hyperuricemia, this was the case in only 10% of VFO subjects. While 44% of VFO subjects with hyperuricemia were designed as an overproduction type. These results suggest that the mechanism of hyperuricemia in obesity may be affected by the difference in body fat distribution and that the assessment of body fat distribution and types of hyperuricemia is crucial for the treatment of obese patients with hyperuricemia.

No full text is available. To read the body of this article, please view the PDF online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported by a Grant No. 07671132 from the Ministry of Education, Science, Sports, and Culture of Japan, and by a grant from the Uehara Memorial Foundation, 1996.

PII: S0026-0495(98)90346-8

Metabolism - Clinical and Experimental
Volume 47, Issue 8 , Pages 929-933, August 1998